Πέμπτη 20 Απριλίου 2017

A phase 2 study of temozolomide in pretreated metastatic colorectal cancer with MGMT promoter methylation

A phase 2 study of temozolomide in pretreated metastatic colorectal cancer with MGMT promoter methylation

British Journal of Cancer advance online publication, April 20 2017. doi:10.1038/bjc.2017.109

Authors: M A Calegari, A Inno, S Monterisi, A Orlandi, D Santini, M Basso, A Cassano, M Martini, T Cenci, I de Pascalis, F Camarda, B Barbaro, L M Larocca, S Gori, G Tonini & C Barone



from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2oWwnln
via IFTTT

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου

Δημοφιλείς αναρτήσεις